Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!


Vertically integrated, multi-state cannabis operator and retailer, 4Front Ventures just announced its financial results for the first quarter 2021. What are the highlights?

  • Q1 2021 Systemwide Pro Forma Revenue of $31.4 million, an increase of 26% over Q4 2020
  • Q1 2021 Adjusted EBITDA of $5.9 million, representing an Adjusted EBITDA Margin of 19%
  • Reiterated FY2021 guidance for Systemwide Pro Forma Revenue of $170-180 million and Adjusted EBITDA of $40-50 million
  • The Company’s existing licensed projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million, respectively

4Front Ventures Reports First Quarter 2021 Financial Results

PHOENIX, Ariz.May 24, 2021 /PRNewswire/ – 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”), a vertically integrated, multi-state cannabis operator and retailer, today announced its financial results for the first quarter ended March 31, 2021. All financial information is presented in U.S. dollars unless otherwise indicated.

Symbol Name Last Price Change % Change

First Quarter 2021 (“Q1 2021”) Financial Results Highlights

  • Systemwide Pro Forma Revenue was $31.4 million
  • GAAP-reported revenue was $23.0 million
  • Adjusted EBITDA was $5.9 million

Operational Highlights

  • Strong performance in sales and product adoption across retail locations, exceeding all internal projections; positive momentum continues in Q2
  • California
    • Company’s state-of-the-art 170,000 square foot production facility in Commerce, California is on track for planned Q2 2021 opening
    • Certificate of Occupancy anticipated in the next ten days
    • Signed distribution agreement with Nabis, a leading wholesale cannabis distributor to more than 750 stores in California
  • Massachusetts
    • The Company received its Certificate of Occupancy and approval to operate from the Town of Brookline for its third adult-use dispensary in Massachusetts
    • Grand opening in June 2021 pending final approval from the Cannabis Control Commission
  • Illinois
    • Secured land and funding for new cultivation and production facility in Illinois; groundbreaking scheduled to occur in Q3 2021

4Front Ventures Reports First Quarter 2021 Financial Results

4Front Ventures Reports First Quarter 2021 Financial Results

Management Commentary

“Our strategy of replicating low-cost production methods in new markets began to take shape and grow at scale in MassachusettsIllinois and California in our first quarter, extending the momentum we created in 2020,” said Leo Gontmakher, Chief Executive Officer of 4Front. “Utilizing the cultivation and production techniques developed for our facilities in Washington, we have increased the yields and quality of our products produced in both Illinois and Massachusetts, which has enabled us to supply our adult use dispensaries to meet the ever-increasing demand in those markets. As production increases, we plan to begin selling excess product into the wholesale market as well.”

Mr. Gontmakher added, “Continued positive momentum following the initiation of adult use sales in late 2020 in both Georgetown and Worcester, Massachusetts, along with an exceptionally strong launch of our Calumet City, Illinois dispensary in December, contributed to our robust sequential Q1 sales increases and exceeded all internal expectations. Looking ahead, with the completion and opening of our manufacturing facility in Commerce, California just a few weeks out, we expect to be in the market imminently with our suite of high-quality, branded products. As the largest legal cannabis market in the world, California offers a unique opportunity to build efficient operations and create incredible products that are replicable across our nationwide footprint.”

Mr. Gontmakher concluded, “With revenue-generating operations now in CaliforniaIllinoisMassachusettsMichigan, and Washington, we are poised to further scale the business according to our expansion strategy for 2021. We continue to track towards our stated financial guidance for the year, anticipating $170$180 million in Pro Forma Systemwide Revenue and $40$50 million in Adjusted EBITDA.”

Best Hemp Stocks 2021 - Cannin Report

Business Updates and Developments

Systemwide pro forma revenue increased 26% to $31.4 million in Q1 2021, compared to $25.0 million in Q4 2020. Retail sales and product adoption exceeded internal expectations. This increase was primarily due to higher sales from the two Massachusetts dispensaries following the start of adult use sales in the second half of 2020, and a very strong launch from the Calumet City dispensary that opened in December 2020.

Q1 2021 Adjusted EBITDA was $5.9 million, steady with Q4 2020 representing an adjusted EBITDA margin of 19%. EBITDA margin in the quarter was negatively impacted by the ramp up of the Company’s expanded grow facility in Illinois. While the tripling of the Company’s Illinois cultivation facility’s flowering canopy was completed on time and under budget, the first harvest from the expanded facility was not completed until April, leading to a one-time, higher than expected average cost per gram for manufactured products in Q1 2021. Through the first month of Q2, 4Front has more than tripled its Illinois harvest output and expects a meaningful rebound in margins in Q2.

The Company’s fully-funded, state-of-the-art 170,000 square foot manufacturing facility in Commerce, California is nearing completion and remains on track to be ready to serve the California cannabis market beginning in Q2 2021. The Company’s first suite of products will include edibles, tinctures, capsules and infused pre-rolls, including Marmas™, Pebbles™, Chewees™, Hi-Burst™, Verdure™ and Terp Stix™. The Company has signed a distribution agreement with Nabis, a leading distributor of cannabis products. Nabis distributes brands to more than 750 dispensaries in California, covering 99% of licensed retailers in the state.

4Front Ventures Reports First Quarter 2021 Financial Results

Construction of the Company’s third Massachusetts Mission Dispensary in Brookline is complete. The Company also announced that it has cleared all municipal processes with the City of Brookline including receiving its Certificate of Occupancy. Pending final approval from the Cannabis Control Commission, the grand opening is slated for June 2021.

In Illinois, the recently announced development of our new cultivation and production facility continues as scheduled with construction beginning in Q3 2021. The first phase, a 258,000 square foot building with 65,000 square feet of flowering canopy and approximately 70,000 square feet of manufacturing space is on track to break ground in Q3 2021.

4Front Ventures Reports First Quarter 2021 Financial Results

Conference Call

The Company will host a conference call and webcast on Monday, May 24, 2021 at 5:00 p.m. ET to review its operational and financial results and provide an update on current business trends.

To join the call, dial 1-877-407-0792 toll free from the United States or Canada or 1-201-689-8263 if dialing from outside those countries. The webcast can be accessed at this link.

The call will be available for replay until Monday, May 31, 2021. To access the telephone replay, dial 1-844-512-2921 toll free from the United States and Canada, or 1-412-317-6671 if dialing from outside those countries, and use this replay pin number: 13719936.

About 4Front Ventures Corp.

4Front (CSE: FFNT) (OTCQX: FFNTF) is a national multi-state cannabis operator and retailer, with a market advantage in mass-produced, low-cost quality branded cannabis products. 4Front manufactures and distributes a portfolio of over 21 cannabis brands including Marmas, Crystal Clear, Funky Monkey, Pebbles, and the Pure Ratios wellness collection, distributed through retail outlets and their chain of strategically positioned Mission branded dispensaries. Headquartered in Phoenix, Arizona, 4Front has operations in IllinoisMassachusettsCaliforniaMichigan, and Washington state. From plant genetics to the cannabis retail experience, 4Front’s team applies expertise across the entire cannabis value chain. For more information, visit www.4frontventures.com.

4Front Ventures Reports First Quarter 2021 Financial Results

Financial Statements

4FRONT VENTURES CORP.
Formerly 4Front Holdings, LLC
Consolidated Balance Sheets
As of March 31, 2021 and December 31, 2020

March 31,
2021

December 31,
2020

ASSETS

Current assets:

Cash

$

17,806

$

18,932

Accounts receivable

390

437

Other receivables

195

1,341

Current portion of lease receivables

3,495

3,450

Inventory

18,971

18,037

Current portion of notes receivable

292

264

Prepaid expenses

3,105

2,275

Total current assets

44,254

44,736

Property and equipment, net

39,542

33,618

Notes receivable and accrued interest

91

Lease receivables

7,486

7,595

Intangible assets, net

28,207

28,790

Goodwill

23,155

23,155

Right-of-use assets

61,593

62,466

Deposits

4,685

4,305

TOTAL ASSETS

$

208,922

$

204,756

LIABILITIES AND SHAREHOLDERS’ EQUITY

LIABILITIES

Current liabilities:

Accounts payable

$

6,576

$

4,722

Accrued expenses and other current liabilities

8,213

6,427

Taxes payable

13,308

11,502

Derivative liability

8,339

5,807

Current portion of convertible notes

2,160

1,652

Current portion of lease liability

1,795

1,909

Current portion of contingent consideration payable

2,393

Current portion of notes payable and accrued interest

3,852

3,372

Total current liabilities

44,243

37,784

Convertible notes

11,466

14,722

Notes payable and accrued interest from related party

45,704

45,362

Long term notes payable

1,838

1,907

Long term accounts payable

1,600

1,600

Contingent consideration payable

3,212

3,103

Deferred tax liability

7,162

6,530

Lease liability

51,334

51,545

TOTAL LIABILITIES

166,559

162,553

SHAREHOLDERS’ EQUITY (DEFICIENCY)

Equity attributable to 4Front Ventures Corp.

259,431

250,583

Additional paid-in capital

44,512

42,116

Deficit

(261,637)

(250,548)

Total 4Front Ventures Corp. shareholders’ equity

42,306

42,151

Non-controlling interest

57

52

TOTAL SHAREHOLDERS’ EQUITY

42,363

42,203

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$

208,922

$

204,756

4FRONT VENTURES CORP.
Formerly 4Front Holdings, LLC
Consolidated Statements of Operations and Comprehensive Loss
For the Three Months Ended March 31, 2021 and March 31, 2020

Three Months Ended March 31,

2021

2020

REVENUE

Revenue from sale of goods

$

20,080

$

9,755

Real estate income

2,890

2,897

Total revenues

22,970

12,652

Cost of goods sold, sale of grown and manufactured products

(5,335)

(2,815)

Cost of goods sold, sale of purchased products

(3,790)

(1,834)

Gross profit

13,845

8,003

OPERATING EXPENSES

Selling and marketing expenses

5,157

6,816

General and administrative expenses

5,165

5,108

Equity based compensation

2,396

1,227

Depreciation and amortization

774

913

Accretion

(37)

Total operating expenses

13,492

14,027

Income (Loss) from operations

353

(6,024)

Other income (expense)

Interest income

3

56

Interest expense

(2,461)

(2,136)

Amortization of loan discount upon conversion of debt to equity

(2,915)

Change in fair value of derivative liability

(2,532)

Loss on lease termination

(879)

Total other income (expense)

(8,784)

(2,080)

Net loss before income taxes

(8,431)

(8,104)

Income tax expense

(2,653)

(550)

Net loss from continuing operations, net of taxes

(11,084)

(8,654)

Net income from discontinued operations, net of taxes

872

Net loss

(11,084)

(7,782)

Net loss attributable to non-controlling interest

5

12

Net loss attributable to shareholders

$

(11,089)

$

(7,794)

Basic and diluted loss per share

$

(0.02)

$

(0.01)

Weighted average number of shares outstanding, basic and diluted

558,997,571

531,521,620

Note Regarding Non-GAAP Measures, Reconciliation, and Discussion

In this press release, 4Front refers to certain non-GAAP financial measures such as Systemwide Pro Forma Revenue and Adjusted EBITDA. These measures do not have any standardized meaning prescribed by GAAP and may not be comparable to similar measures presented by other issuers. 4Front defines Systemwide Pro Forma Revenue as total revenue plus revenue from entities with which the Company has a management contract, or effectively similar relationship (net of any management fee or effectively similar revenue) but does not consolidate the financial results of per U.S. GAAP ASC 810. 4Front considers this measure to be an appropriate indicator of the growth and scope of the business.

4Front Ventures Reports First Quarter 2021 Financial Results

Adjusted EBITDA is defined by the Company as earnings before interest, taxes, depreciation and amortization less share-based compensation expense and one-time charges related to acquisition, financing related costs and other non-recurring expenses. 4Front considers these measures to be an important indicator of the financial strength and performance of our business.

Best Cannabis Stocks 2021

This news release was prepared by management of 4Front Ventures, which takes full responsibility for its contents. The Canadian Securities Exchange (“CSE”) has not reviewed and does not accept responsibility for the adequacy of this news release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States.

4Front Ventures Reports First Quarter 2021 Financial Results

Systemwide Pro Forma Revenue Reconciliation

Revenue (GAAP) 

$22,970

Less: Real Estate Income 

2,890

Plus: Systemwide Revenue Adjustment 

11,322

Systemwide Pro Forma Revenue (non-GAAP) 

$31,402

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in 4Front Ventures’ periodic filings with securities regulators. When used in this news release, words such as “will, could, plan, estimate, expect, intend, may, potential, believe, should,” and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to future developments and the business and operations of 4Front Ventures, statements regarding when or if transactions will close or if/when required conditions to closing are attained, the impact of the transactions on the business of 4Front and other statements regarding future developments of the business. Although 4Front Ventures has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on satisfying closing conditions, [obtaining regulatory approvals]; and engagement in activities currently considered illegal under U.S. federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. 4Front Ventures disclaims any intention or obligation to update or revise such information, except as required by applicable law, and 4Front Ventures does not assume any liability for disclosure relating to any other company mentioned herein.

SOURCE 4Front

Related Links

https://4frontventures.com

4Front Ventures Reports First Quarter 2021 Financial Results


About Cannin: Your Cannabis Stocks Resource

78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.

Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. We aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021. 

Use Cannin as your resource for:

Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.

Are you looking to buy stock in hemp companies or marijuana companies for 2021? Interested in new penny hemp stock companies? Looking for the best Canadian cannabis stocks to invest in? Looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.

Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • Backtested since 2012

We’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best cannabis stocks – we’ll show you how at cannin.com.